Your browser doesn't support javascript.
loading
A prospective study of XELIRI plus bevacizumab as a first-line therapy in Japanese patients with unresectable or recurrent colorectal cancer (KSCC1101).
Ando, Koji; Emi, Yasunori; Suenaga, Toyokuni; Hamanoue, Masahiro; Maekawa, Soichiro; Sakamoto, Yasuo; Kai, Seiichiro; Satake, Hironaga; Shimose, Takayuki; Shimokawa, Mototsugu; Saeki, Hiroshi; Oki, Eiji; Sakai, Kenji; Akagi, Yoshito; Baba, Hideo; Maehara, Yoshihiko.
Afiliación
  • Ando K; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Emi Y; Department of Surgery, Saiseikai Fukuoka General Hospital, Fukuoka, Japan.
  • Suenaga T; Surgery/Gastrointestinal Surgery, Public Interest Incorporated Association, Kagoshima, Nanpuh Hospital, Kagoshima, Japan.
  • Hamanoue M; Department of Surgery, Imakiire General Hospital, Kagoshima, Japan.
  • Maekawa S; Department of Surgery, Munakata Medical Association Hospital, Fukuoka, Japan.
  • Sakamoto Y; Department of Gastroenterological Surgery, Kumamoto University Hospital, Kumamoto, Japan.
  • Kai S; Department of Surgery, Nakatsu Municipal Hospital, Oita, Japan.
  • Satake H; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Shimose T; Clinical Research Support Center Kyushu, Fukuoka, Japan.
  • Shimokawa M; Department of Cancer Information Research, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Saeki H; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Oki E; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. okieiji@surg2.med.kyushu-u.ac.jp.
  • Sakai K; Department of Medical Oncology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
  • Akagi Y; Department of Surgery, School of Medicine, Kurume University, Fukuoka, Japan.
  • Baba H; Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Maehara Y; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Int J Clin Oncol ; 22(5): 913-920, 2017 Oct.
Article en En | MEDLINE | ID: mdl-28526907
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_diarrhea / 3_neglected_diseases Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_diarrhea / 3_neglected_diseases Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Japón